Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries
- PMID: 33485461
- PMCID: PMC7846817
- DOI: 10.1016/S0140-6736(21)00001-5
Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries
Erratum in
-
Department of Error.Lancet. 2021 Mar 6;397(10277):880. doi: 10.1016/S0140-6736(21)00456-6. Lancet. 2021. PMID: 33676626 Free PMC article. No abstract available.
Abstract
Background: 80% of individuals with cancer will require a surgical procedure, yet little comparative data exist on early outcomes in low-income and middle-income countries (LMICs). We compared postoperative outcomes in breast, colorectal, and gastric cancer surgery in hospitals worldwide, focusing on the effect of disease stage and complications on postoperative mortality.
Methods: This was a multicentre, international prospective cohort study of consecutive adult patients undergoing surgery for primary breast, colorectal, or gastric cancer requiring a skin incision done under general or neuraxial anaesthesia. The primary outcome was death or major complication within 30 days of surgery. Multilevel logistic regression determined relationships within three-level nested models of patients within hospitals and countries. Hospital-level infrastructure effects were explored with three-way mediation analyses. This study was registered with ClinicalTrials.gov, NCT03471494.
Findings: Between April 1, 2018, and Jan 31, 2019, we enrolled 15 958 patients from 428 hospitals in 82 countries (high income 9106 patients, 31 countries; upper-middle income 2721 patients, 23 countries; or lower-middle income 4131 patients, 28 countries). Patients in LMICs presented with more advanced disease compared with patients in high-income countries. 30-day mortality was higher for gastric cancer in low-income or lower-middle-income countries (adjusted odds ratio 3·72, 95% CI 1·70-8·16) and for colorectal cancer in low-income or lower-middle-income countries (4·59, 2·39-8·80) and upper-middle-income countries (2·06, 1·11-3·83). No difference in 30-day mortality was seen in breast cancer. The proportion of patients who died after a major complication was greatest in low-income or lower-middle-income countries (6·15, 3·26-11·59) and upper-middle-income countries (3·89, 2·08-7·29). Postoperative death after complications was partly explained by patient factors (60%) and partly by hospital or country (40%). The absence of consistently available postoperative care facilities was associated with seven to 10 more deaths per 100 major complications in LMICs. Cancer stage alone explained little of the early variation in mortality or postoperative complications.
Interpretation: Higher levels of mortality after cancer surgery in LMICs was not fully explained by later presentation of disease. The capacity to rescue patients from surgical complications is a tangible opportunity for meaningful intervention. Early death after cancer surgery might be reduced by policies focusing on strengthening perioperative care systems to detect and intervene in common complications.
Funding: National Institute for Health Research Global Health Research Unit.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Figures





Comment in
-
High burden of postoperative cancer mortality in LMICs.Lancet. 2021 Jan 30;397(10272):349-351. doi: 10.1016/S0140-6736(21)00187-2. Lancet. 2021. PMID: 33516321 No abstract available.
Similar articles
-
Impact of malnutrition on early outcomes after cancer surgery: an international, multicentre, prospective cohort study.Lancet Glob Health. 2023 Mar;11(3):e341-e349. doi: 10.1016/S2214-109X(22)00550-2. Lancet Glob Health. 2023. PMID: 36796981
-
Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study.Lancet Glob Health. 2022 Jul;10(7):e1003-e1011. doi: 10.1016/S2214-109X(22)00168-1. Epub 2022 May 24. Lancet Glob Health. 2022. PMID: 35623378 Free PMC article.
-
Quality and outcomes in global cancer surgery: protocol for a multicentre, international, prospective cohort study (GlobalSurg 3).BMJ Open. 2019 May 24;9(5):e026646. doi: 10.1136/bmjopen-2018-026646. BMJ Open. 2019. PMID: 31129582 Free PMC article.
-
Global patterns of mortality in international migrants: a systematic review and meta-analysis.Lancet. 2018 Dec 15;392(10164):2553-2566. doi: 10.1016/S0140-6736(18)32781-8. Epub 2018 Dec 5. Lancet. 2018. PMID: 30528484 Free PMC article.
-
Tuberculosis.In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.
Cited by
-
Impact of preoperative uni- or multimodal prehabilitation on postoperative morbidity: meta-analysis.BJS Open. 2023 Nov 1;7(6):zrad129. doi: 10.1093/bjsopen/zrad129. BJS Open. 2023. PMID: 38108466 Free PMC article.
-
Three Potential Tumor Markers Promote Metastasis and Recurrence of Colorectal Cancer by Regulating the Inflammatory Response: ADAM8, LYN, and S100A9.Comput Math Methods Med. 2022 Jan 22;2022:3118046. doi: 10.1155/2022/3118046. eCollection 2022. Comput Math Methods Med. 2022. Retraction in: Comput Math Methods Med. 2023 Dec 6;2023:9850491. doi: 10.1155/2023/9850491. PMID: 35103068 Free PMC article. Retracted.
-
Major surgical postoperative complications and survival in breast cancer: Swedish population-based register study in 57 152 women.Br J Surg. 2022 Sep 9;109(10):977-983. doi: 10.1093/bjs/znac275. Br J Surg. 2022. PMID: 35929050 Free PMC article.
-
A formula for survival in surgery.Patient Saf Surg. 2023 May 27;17(1):13. doi: 10.1186/s13037-023-00362-z. Patient Saf Surg. 2023. PMID: 37245020 Free PMC article. No abstract available.
-
Breaking the shield of solid tumors: a combined approach for enhanced efficacy of CAR-T cells.Cancer Immunol Immunother. 2024 Nov 2;74(1):3. doi: 10.1007/s00262-024-03817-z. Cancer Immunol Immunother. 2024. PMID: 39487875 Free PMC article. Review.
References
-
- Global Burden of Disease Cancer Collaboration. Fitzmaurice C, Allen C. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study. JAMA Oncol. 2017;3:524. - PMC - PubMed
-
- Sullivan R, Alatise OI, Anderson BO. Global cancer surgery: delivering safe, affordable, and timely cancer surgery. Lancet Oncol. 2015;16:1193–1224. - PubMed
-
- Meara JG, Leather AJM, Hagander L. Global surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet. 2015;386:569–624. - PubMed
-
- Nepogodiev D, Moore R, Biccard B. Prioritizing research for patients requiring surgery in low- and middle-income countries. Br J Surg. 2019;106:e113–e120. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous